Computationally Designed Peptide Nanopores Target Drug-Resistant Bacteria in Preclinical Models

Researchers report a computational strategy for designing alphahelical peptides that selfassemble into membranespanning nanopores. A tuned lead peptide disrupted bacterial membranes, showed selectivity in laboratory testing, and demonstrated activity in preclinical mouse infection models.

For research use only. Not for human consumption.